Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, ...

YONGIN, South Korea--(BUSINESS WIRE)--GC Labs (CEO, Dr. Eun-hee Lee), the leading clinical diagnostics company in Korea, today announced the new lab testing service agreement with two partners: Bio ...

Disclosure of secondary germline findings from clinical tumor-normal paired somatic mutation profiling. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not ...

Differences in Health Care Use and Costs Among Patients With Cancer Receiving Intravenous Chemotherapy in Physician Offices Versus in Hospital Outpatient Settings With increased demand for hereditary ...